Is Hepatitis C Infection Associated with Increased Risk of Depression in Persons with Methamphetamine Dependence?

REFERENCES

• Konuma K. Use and abuse of amphetamines in Japan. In: Cho A, Segal D, eds. Amphetamine and Its Analogs. San Diego: Academic Press; 1994:503.
   Google Scholar
• National Institute of Justice. Methamphetamine Matters: Report on Methamphetamine Users in Five Western Cities. Washington, DC: U.S. Department of Justice; 1999.
   Google Scholar
• Semple SJ, Patterson TL, Grant I. Methamphetamine use and depressive symptoms among heterosexual men and women. J Subst Use. 2005;10:31–47.
   Google Scholar
• Gorman M, Gunderson R, Mariatt A, Donovan D. HIV risk among gay and bisexual methamphetamine injectors in Seattle, Washington. 11th International Conference on AIDS. Vancouver, BC, Canada, 1996.
   Google Scholar
• Morgan P. Researching Hidden Communities: A Quantitative Comparative Study of Methamphetamine Use in Three Sites. Epidemiologic Trends in Drug Abuse. Washington, D.C.: U.S. Department of Health and Human Services, National Institute of Drug Abuse; 1994.
   Google Scholar
• Rotheram-Borus MJ, Mann T, Chabon C. Amphetamine use and its correlates among youths living with HIV. AIDS Educ Prev. 1999;11:232–242.
   PubMed Web of Science ®Google Scholar
• Siever MD. Stimulant abuse treatment and HIV. Focus: A guide to AIDS Research and Counseling. 1998;13:4–6.
   Google Scholar
• Beck AT, Steer RA. Beck Depression Inventory. San Antonio: Psychological Corporation; 1987.
   Google Scholar
• London ED, Simon SL, Berman SM, , et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004;61:73–84.
   PubMed Web of Science ®Google Scholar
• Sekine Y, Iyo M, Ouchi Y, , et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001;158:1206–1214.
   PubMed Web of Science ®Google Scholar
• Sekine Y, Minabe Y, Kawai M, , et al. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms: a Proton MRS study. Neuropsychopharmacology. 2002;27:453–461.
   Google Scholar
• Reiber C, Galloway G, Cohen J, Hsu JC, Lord RH. A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months. J Psychoactive Drugs. 2000;32:183–191.
   PubMed Web of Science ®Google Scholar
• Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan FM, Gao F, Moyer LA. The prevalence of Hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–562.
   PubMed Web of Science ®Google Scholar
• Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K. Hepatitis C virus in intravenous drug users. The Medical Journal of Australia. 1990;153:274–276.
   PubMed Web of Science ®Google Scholar
• Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse. 1999;25:475–493.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Vlahov D, Solomon L, , et al. Correlates of Hepatitis C virus infections among injection drug users. Medicine. 1995;74:212–220.
   PubMed Web of Science ®Google Scholar
• Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic Hepatitis C. J Psychosom Res. 2000;49:311–317.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition. Washington, DC: American Psychiatric Association; 1994.
   Google Scholar
• Hilsabeck RC, Malek-Ahmadi P. Neurobehavioral correlates of chronic Hepatitis C. Journal of Psychopathology and Behavioral Assessment. 2004;26:203–210.
   Web of Science ®Google Scholar
• McNair DM, Lorr M, Droppelman LF. Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service; 1981.
   Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders. New York: Biometrics Research Department; 1996.
   Google Scholar
• Kessler RC, Berglund P, Demler O, , et al. The epidemiology of major depressive disorder. JAMA. 2003;289:3095–3105.
   PubMed Web of Science ®Google Scholar
• Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States. Arch Gen Psychiatry. 2002;59:115–123.
   PubMed Web of Science ®Google Scholar
• Johnson ME, Fisher DG, Fenaughty A, Theno SA. Hepatitis C Virus and depression in drug users. Am J Gastroenterol. 1998;93:785–789.
   PubMed Web of Science ®Google Scholar
• Mazure CM, Bruce ML, Maciejewski PK, Jacobs SC. Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response. Am J Psychiatry. 2000;157:896–903.
   PubMed Web of Science ®Google Scholar
• RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999;50:1427–1434.
   PubMed Web of Science ®Google Scholar